IMPCL Ties Up With Government E-Market Portal To Sell Its Products Online

Mumbai : The Indian Medicines Pharmaceutical Corporation Limited (IMPCL), the public sector manufacturing unit of the Union Ministry of Ayush, has tied up with the government e-market (GeM) portal for selling its products online.

The deal between IMPCL and GeM was finalised on March 03, 2021 when GeM created 31 categories covering 311 medicines, which are live in the marketplace and IMPCL can now upload these medicines on GeM portal, said the statement issued by the Union Ministry of Ayush.

IMPCL, the Rs. 100 crore turnovers PSU of the Union Ministry of Ayush, is one of the most trusted manufacturers of Ayush medicines in the country, and is known for the authenticity of its formulations. Following the tie-up, ayurvedic and Unani medicines of IMPCL will figure on the GeM portal to hundreds of government sector buyers at prices finalised by the Union ministry of finance, it further stated.

This will facilitate quick procurement of these medicines by Central/state government institutions for their healthcare programmes. Thus, this tie-up between GeM & IMPCL also helps to streamline the procurement and distribution of ayurvedic and Unani medicines by state units.

The thousands of patients and other clients who visit government Ayush hospitals every day stand to gain because of this increased availability of such medicines even in far-flung Ayush hospitals and clinics.

The Central government has approved 12,500 Ayush health and wellness centres to be operationalized by Union Ministry of Ayush through State/UT governments under Centrally Sponsored Scheme of National Ayush Mission (NAM) in a phased manner by the year 2023-24. It is envisaged to upgrade Ayush dispensaries and sub-health centres identified by state/UT governments as Ayush health and wellness centres for providing Ayush based preventive, primitive, curative and rehabilitative care.

  • Related Posts

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    NEW DELHI: Medical technology innovation is entering a new phase, with advanced cardiac implants, incisionless brain surgery, blood-based cancer screening, smart insulin delivery and real-time kidney-function monitoring among the technologies…

    Three arrested after liquor bottles found at pharma firm

    Patna: Three people were arrested and sent to jail after a large quantity of liquor bottles was found at Cellulas Pharma Private Limited in Kankarbagh during a raid by the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    Three arrested after liquor bottles found at pharma firm

    Three arrested after liquor bottles found at pharma firm

    NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

    NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

    National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

    National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

    Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

    Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

    Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

    Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources